Covid US: At least three fully vaccinated Hawaiians contracted the infection


At least three Hawaiian residents have been infected with COVID-19, despite being fully vaccinated against the disease.

Vaccine trials showed that the three vaccines approved in the US prevent between 66 and 95 percent of symptomatic infections, but we don’t yet know how well the vaccines prevent people from contracting or spreading the coronavirus.

Therefore, it is not surprising that some people test positive even after being vaccinated. But none of the people who tested positive became seriously ill, showing that vaccines work well to reduce illness caused by the coronavirus.

One of the three people traveled to the mainland after receiving both injections of a two-dose vaccine, made by Pfizer or Moderna.

It is not clear which vaccine the other two people received. All three vaccines licensed in the US are available in Hawaii, although the vast majority of the supply shipped to Hawaii and the US has generally been from Pfizer or Moderna.

Only a few doses shipped to Hawaii came from Johnson & Johnson, and the first of those single-dose injections arrived there on March 5, after at least two of the major cases were identified.

They are the latest examples of “revolutionary infections” and doctors say they are neither common nor surprising.

None of the three people who developed progressive infections have become seriously ill and, as far as local officials know, none of them have transmitted the virus to anyone else, the state health department told KITV4.

At least three people in Hawaii have been infected with COVID-19, despite being fully vaccinated against the disease, health officials relieved them.

At least three people in Hawaii have been infected with COVID-19, despite being fully vaccinated against the disease, health officials relieved them.

Hawaii continues to see about 70 cases a day, with a slight rebound this month.

Hawaii continues to see about 70 cases a day, with a slight rebound this month.

Currently, only five people are being treated for COVID-19 in ICUs in the entire state of Hawaii.

That’s less than the September peak of 56, doctors told KITV4.

In particular, one of the most significant cases is an Oahu healthcare worker who had traveled not to one, but to several cities in the US after being vaccinated.

That person received two doses of the vaccine, meaning they received the Moderna or Pfizer vaccine, and completed their regimen in January.

The healthcare worker and a fellow traveler underwent coronavirus tests before leaving Hawaii for a trip to the continental US, but their results didn’t come in until they returned to Oahu.

Both people tested positive for COVID-19, but contact tracing did not identify additional infections among the close contacts of the two travelers.

It’s an issue that was raised at the White House Covid response team briefing on Monday.

When asked if fully vaccinated people can start traveling, the director of the Centers for Disease Control and Prevention, Rochelle Walensky, firmly answered: no.

“In relation to spring break, they are not the demographic that we have focused on when it comes to travel,” he said.

But even if people who are vaccinated travel, ‘they go out and mingle with people who are not vaccinated … we are so close to vaccinating so many other people so I would just encourage and remind people that now is not the time! time to travel.

Scientists believe that the more a person is exposed to the coronavirus, the more likely they are to contract and become ill from the infection they have.

Only five people are hospitalized in ICUs in all of Hawaii, up from 56 in September

Only five people are hospitalized in ICUs in all of Hawaii, up from 56 in September

Dr. Melinda Ashton, Hawaii Pacific Health Director of Quality, said the groundbreaking cases are a reminder that people must be `` absolutely '' careful when traveling.

Dr. Melinda Ashton, Hawaii Pacific Health Director of Quality, said the groundbreaking cases are a reminder that people must be “ absolutely ” careful when traveling.

This is likely to remain true for vaccinated people. Antibodies activated by vaccines, which are 66 to 95 percent effective, are excellent at ‘neutralizing’ the virus, but may be more likely to fail if faced with attack after attack from infectious particles.

In addition, the risk of infection despite vaccination has increased slightly, with variants circulating, including the South African, Brazilian, Californian, and New York City variants, all of which have shown some ability to evade antibodies.

It is unclear if any of the three breakthrough infections were caused by variants or if patient samples are being tested for variants.

The state health department did not immediately respond to request for comment.

But an authority from one of the state hospitals warned against the trips.

“You absolutely have to be careful during those times when you’re at the airport, on the plane, with other people in larger groups,” Dr. Melinda Ashton, Hawaii Pacific Health Director of Quality, told KITV4.

So far breakthrough infections have been quite rare.

The CDC says it is investigating all major case reports, but has not yet publicly shared national rates.

Scientists at the national agency will collect data on these infections in part to find out how common they are, which is difficult to establish because many, if not most, are likely to be asymptomatic.

HOW DO THE THREE US AUTHORIZED COVID-19 VACCINES COMPARE?

PFIZER

WHEN WAS IT APPROVED? December 11, 2020

WHO CAN GET IT? Anyone 16 years of age or older

DOSE: 2 doses, given 21 days apart

HOW DOES IT WORK? It uses messenger RNA to deliver a small piece of the virus’s genetic code to ‘teach’ the body to make a protein that triggers the production of antibodies.

HOW EFFECTIVE IS …

AFTER 2 DOSES: 95% effective in preventing disease; 100% effective in preventing death from COVID-19; 87% effective in preventing hospitalization

AFTER THE FIRST DOSE: (not recommended) ~ 46% effective in preventing infection seven to 20 days later; 57% effective against symptomatic diseases; 72% effective in preventing death; 74% effectiveness against hospitalization; 62% effective against serious diseases (based on real world data from Israel)

AGAINST VARIANTS OF …

United Kingdom – B117: No significant impact

South Africa – B1351: 10% less effective; still protective

Brazil – P1: Antibodies 10.4 times weaker; still protective

Modern

WHEN WAS IT APPROVED? December 18, 2020

WHO CAN GET IT? Anyone over 18 years of age

DOSE: 2 doses, administered 28 days apart

HOW DOES IT WORK? It uses messenger RNA to deliver a small piece of the virus’s genetic code to ‘teach’ the body to make a protein that triggers the production of antibodies.

HOW EFFECTIVE IS …

AFTER 2 DOSES: 94% effective in preventing diseases; 100% effective in preventing death from COVID-19; 89% effective in preventing hospitalization

AFTER THE FIRST DOSE: (not recommended) ~ 80% effective, based on test data

AGAINST VARIANTS OF …

United Kingdom – B117: No significant impact

South Africa – B1351: 10% less effective; still protective

Brazil – P1: More data is needed

JOHNSON AND JOHNSON

WHEN WAS IT APPROVED? February 27, 2021

WHO CAN GET IT? Anyone over 18 years of age

DOSE: 1 dose

HOW DOES IT WORK? Uses an inactivated, harmless cold virus to deliver a serving of spike protein to the body and teach it to fight SARS-CoV-2

HOW EFFECTIVE IS …

AFTER A SINGLE DOSE: 72% worldwide; 86% in the US

AGAINST VARIANTS OF …

United Kingdom – B117: No significant impact

South Africa – B1351: 64% effective

Brazil – P1: 85% effective

.

Source link